Loading company…
Won a federal SBIR/STTR research award from HHS and other federal agencies.
GT MOLECULAR, INC. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $256,575 in 2022. These are non-dilutive federal research grants, not equity financing. The company is based in FORT COLLINS, Colorado.
No investors recorded yet for GT MOLECULAR, INC..
Add an investorGT MOLECULAR, INC. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for GT MOLECULAR, INC..
Add diversity data